ReviewFrontiers in immunology2021

Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma.

Emily J Lelliott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.